RE:RE:RE:RE:RE:RE:Roche experiences second failure in Alzheimer's diseaseMatt said 6 to 9 months for news on a phase 3. In the past they have been clear there is no phase 3 without a partner.
That seems pretty solid from my viewpoint. I think we can expect to hear about a partner within 6-9 months on two phase 3 trials.
Of course, ithese words would most likely be smoke and mirrors, and easily dismissed as more of the same, if not for the spectacular results.
People have been disappointed for years with this company. But in retrospect, it was always going to be that way until they partnered, because this is an odd-ball approach to cancer treatment and an odd-ball company. (Perhaps I should have thought about that 10 years ago, but here we are now).
The latest results cannot be dismissed or ignored. They will carry the day if anything can. What alternatives do Roche or Pfizer have if they want to be in immuno-ocology, patient centered, safe, and build on their existing portfolios?